We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$4.26B
AUM Growth
+$479M
Cap. Flow
+$608M
Cap. Flow %
14.26%
Top 10 Hldgs %
31.08%
Holding
808
New
118
Increased
74
Reduced
47
Closed
122

Sector Composition

Rank Sector Weight
1 Financials 25.33%
2 Technology 11.72%
3 Healthcare 8.7%
4 Industrials 6.46%
5 Consumer Discretionary 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCG icon
401
PG&E
PCG
$38.4B
$1.07M 0.03%
+85,750
New +$1M
ADPT icon
402
Adaptive Biotechnologies
ADPT
$3.9B
$1.04M 0.02%
145,792
+121,102
+490% +$1.14M
ONEM
403
DELISTED
1Life Healthcare
ONEM
$1.03M 0.02%
+60,000
New +$942K
DPCS
404
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
$1.01M 0.02%
100,000
PTCT icon
405
PTC Therapeutics
PTCT
$5.77B
$1M 0.02%
20,000
-20,000
-50% -$980K
PHIC
406
DELISTED
Population Health Investment Co., Inc. Class A Ordinary Share
PHIC
$998K 0.02%
100,000
NVSA
407
DELISTED
New Vista Acquisition Corp Class A Ordinary Shares
NVSA
$994K 0.02%
100,000
FTEV
408
DELISTED
FinTech Evolution Acquisition Group
FTEV
$992K 0.02%
100,000
SPWR icon
409
SunPower Inc
SPWR
$60.2M
$991K 0.02%
100,000
GNAC
410
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
$989K 0.02%
100,000
SWET
411
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
$988K 0.02%
100,000
MEKA
412
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$987K 0.02%
100,000
HCIC
413
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$987K 0.02%
100,000
AEON icon
414
AEON Biopharma
AEON
$13.1M
$985K 0.02%
1,389
MDH
415
DELISTED
MDH Acquisition Corp.
MDH
$985K 0.02%
100,000
ARYE
416
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$983K 0.02%
100,000
JUGG
417
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
$982K 0.02%
100,000
LNZA icon
418
LanzaTech
LNZA
$70.1M
$979K 0.02%
1,000
JD icon
419
JD.com
JD
$44.5B
$895K 0.02%
17,796
+682
+4% +$40.4K
STVN icon
420
Stevanato
STVN
$5.36B
$847K 0.02%
50,000
CLDX icon
421
Celldex Therapeutics
CLDX
$3.07B
$843K 0.02%
29,993
+12,212
+69% +$374K
IT icon
422
Gartner
IT
$12.4B
$833K 0.02%
3,012
-10,201
-77% -$2.86M
SHOP icon
423
CALL
Shopify
SHOP
$160B
$808K 0.02%
+30,000
New +$1.02M
FATE icon
424
Fate Therapeutics
FATE
$300M
$672K 0.02%
+29,993
New +$867K
CYH icon
425
Community Health Systems
CYH
$417M
$666K 0.02%
309,760
+102,615
+50% +$340K

Similar funds

Moore Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Moore Capital Management held 808 positions worth $4.26B, up 13% from $3.78B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Moore Capital Management deployed $608M of net new capital in Q3 2022, opening 118 new positions and adding to 74 existing holdings. Its largest new stake was Deere & Co: 90,049 shares worth $30.1M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Mastercard, an estimated $18.7M trimmed.

  • Moore Capital Management's largest Q3 2022 buy was Deere & Co: 90,049 shares worth $30.1M.
  • Moore Capital Management added most to iShares 20+ Year Treasury Bond ETF in Q3 2022, an estimated $127M increase.
  • Moore Capital Management's biggest Q3 2022 reduction was Mastercard, cutting an estimated $18.7M.
  • Moore Capital Management fully exited State Street Consumer Staples Select Sector SPDR ETF in Q3 2022, selling an estimated $91.8M.
  • Moore Capital Management's ten largest holdings make up 31% of its $4.26B portfolio in Q3 2022.
  • Moore Capital Management opened 118 new positions and closed 122 in Q3 2022.
  • Moore Capital Management's portfolio value rose 13% quarter-over-quarter to $4.26B.

Based on Moore Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.